Skip to main content

Table 4 Incidences of acute GVHD and CMV/EBV infections after ATG-conditioned haploHSCT

From: Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation

  ATG-6 ATG-10 p value
Acute GVHD, n (%)
 Total 21 (72.4) 14 (45.2) 0.03
 Grade II–IV 11 (37.9) 8 (25.8) 0.32
 Grade III–IV 4 (13.8) 2 (6.5) 0.35
Median day of onset grade II-IV aGVHD (range) 29 (10–42) 30 (9–80) 0.32
CMV reactivation, n (%) 22 (75.9) 24 (77.4) 0.89
Median day of onset CMV reactivation (range) 36 (22–77) 37.5 (22–102) 0.73
EBV reactivation, n (%) 2 (6.9) 10 (32.2) 0.02
Median day of onset EBV reactivation (range) 60.5 (47–74) 51 (22–102) 0.61
\